Mads Gyrd-Hansen (@gyrd73) 's Twitter Profile
Mads Gyrd-Hansen

@gyrd73

I am a group leader at Ludwig Cancer Research in Oxford. I am interested in ubiquitin signalling in immune responses and inflammation-associated cancer.

ID: 2371761339

calendar_today28-02-2014 20:23:21

33 Tweet

203 Takipçi

0 Takip Edilen

Gyrd-Hansen Lab (@gyrdlab) 's Twitter Profile Photo

Our study on mechanism of RIPK2 inhibitors in ubiquitin-mediated inflammation is available at The EMBO Journal Congrats to Matous and Lisa! emboj.embopress.org/content/early/…

Our study on mechanism of RIPK2 inhibitors in ubiquitin-mediated inflammation is available at <a href="/embojournal/">The EMBO Journal</a> 
Congrats to Matous and Lisa! 
emboj.embopress.org/content/early/…
Jeremy Farrar (@jeremyfarrar) 's Twitter Profile Photo

Good decision - would have liked to see implemented sooner. Key is to reduce transmission & new infections as soon as possible & get as close as possible to “elimination” before autumn. bbc.co.uk/news/uk-politi…

Ludwig Cancer (@ludwig_cancer) 's Twitter Profile Photo

Ludwig's Oxford Branch is looking for a new Group Leader in cancer epigenetics, a position at the assistant or associate professor level at Oxford! Aside from related experience, applicants should have a PhD or MD and a record of strong publications. bit.ly/2Wpdnhb

Nuffield Department of Medicine (@ndmoxford) 's Twitter Profile Photo

Oxford’s Covid-19 vaccine, devised by Sarah Gilbert, is in human trials. AstraZeneca has lined up agreements to produce 2 billion doses. Now the world waits bloomberg.com/news/features/… via Businessweek

MRC PPU (@mrcppu) 's Twitter Profile Photo

Sascha Roth (@sasomroth) from the Sapkota Lab lab demonstrates targeted degradation of endogenous K-RAS. Read the full story here: ppu.mrc.ac.uk/news/sascha-ro… #research

Sascha Roth (@sasomroth) from the <a href="/sapkota_mrcppu/">Sapkota Lab</a> lab demonstrates targeted degradation of endogenous K-RAS. Read the full story here: ppu.mrc.ac.uk/news/sascha-ro…
#research
Mads Gyrd-Hansen (@gyrd73) 's Twitter Profile Photo

I am delighted to be joining the Leo Foundation Skin Immunology Research Centre and look very much forward to build up a new research team to study Ubiquitin signaling in skin immunology, inflammation and cancer. Honoured to be awarded a Young Investigator award by NNF.

EMBO Press (@embopress) 's Twitter Profile Photo

Journal-independent peer review platform Review Commons ensures referees focus on the science rather than journal fit. Authors choose the right journal fit first time based on objective & structured referee feedback. reviewcommons.org #PeerRevWk20 #TrustInPeerReview EMBO

Ludwig Cancer (@ludwig_cancer) 's Twitter Profile Photo

New studies linking microbiome species/diversity to #immunotherapy effectiveness may help explain why treatment doesn't work for everyone x.com/jamestgallaghe…

Ludwig Cancer (@ludwig_cancer) 's Twitter Profile Photo

Study led by Benoit Van den Eynde of Ludwig Brussels reveals a new mechanism by which #Melanoma can evade #immunotherapy -- and an approach to undoing that mechanism goo.gl/cv5W35

Cell (@cellcellpress) 's Twitter Profile Photo

New issue! cell.com/cell/current #cancer evolution & selection, #microbiome & health, #mitochondria transcription, #immunity, and more!

New issue! cell.com/cell/current #cancer evolution &amp; selection, #microbiome &amp; health, #mitochondria transcription, #immunity, and more!
Ludwig Cancer (@ludwig_cancer) 's Twitter Profile Photo

Ludwig Stanford director Irv Weissman and his team report a second mechanism by which cancer cells avoid being eaten by the immune system's macrophages - and this one too can be disabled. goo.gl/Jd6TKz

Ludwig Cancer (@ludwig_cancer) 's Twitter Profile Photo

Congrats to Ludwig San Diego's Don Cleveland, who won the Breakthrough award for elucidating the cause of an inherited ALS and for developing "designer DNA" drugs for ALS and Huntington's disease UC San Diego Health goo.gl/SnG8Dk goo.gl/9T4zvv

Congrats to Ludwig San Diego's Don Cleveland, who won the Breakthrough award for elucidating the cause of an inherited ALS and for developing "designer DNA" drugs for ALS and Huntington's disease <a href="/UCSDHealth/">UC San Diego Health</a> goo.gl/SnG8Dk goo.gl/9T4zvv